Recorded Pharmacist Educational Series: Gene & Cell Therapy Educational Series: Part 4 - In Vivo & Viral-based Gene Therapy: Education & Supportive Care Considerations

ACPE Activity Number: 0204-0000-25-092-H05-P
Release Date: June 4, 2025
Expiration Date: June 4, 2027
Activity Type: Knowledge-based
CE Credits: 0.5 contact hour
Activity Fee: Member – Free / Non-Member – Not Available

Activity Overview

Gene and cell therapies are quickly integrating into pharmacy practice and present unique challenges not encountered with traditional medications in the clinical pharmacy setting. Health-system pharmacies must take an active role in onboarding these therapies including evaluating biosafety precautions along the medication use pathway, assisting with the development of infrastructure to administer and monitor these therapies, and identifying the practical and financial implications of these therapies within the health-system. 

This activity will provide opportunities for the health-system pharmacist to improve understanding of in vivo and viral-based therapies on an institutional level, outline strategies for toxicity prevention and management, and provide recommendations to ensure availability of supportive care therapies to maintain patient safety, when needed.

Accreditation

Target Audience

Learning Objectives

After participating in this CPE activity, participants should be able to:

Recognize risks, challenges, and patient safety implications associated with the administration of in vivo/viral-based therapies in clinical and research settings.
Identify opportunities to improve management of supportive care therapies used for toxicity prevention.
Identify collaborative strategies with other institutional stakeholders and committees to educate on and safely integrate these novel therapies in the medication use process.

Schedule of Activities

Faculty

Relevant Financial Relationship Disclosure

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

Methods and CE Requirements

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.

Online Program

Member

Free

Non-Member

N/A